scholarly article | Q13442814 |
P50 | author | Laura Esserman | Q91960202 |
P2093 | author name string | Christina Yau | |
Jason T Connor | |||
Kristine Broglio | |||
Martin Eklund | |||
Allison Stover Fiscalini | |||
P2860 | cites work | Statistical issues in randomized trials of cancer screening | Q24791454 |
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society | Q27347760 | ||
Screening and prostate-cancer mortality in a randomized European study | Q29617485 | ||
Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. | Q30238753 | ||
Population-based screening for cancer: hope and hype. | Q30251601 | ||
Cancer screening trials: nuts and bolts | Q34073143 | ||
Effect of screening and adjuvant therapy on mortality from breast cancer | Q34463105 | ||
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement | Q34508652 | ||
Surgical versus nonsurgical therapy for lumbar spinal stenosis | Q34752410 | ||
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening | Q34977428 | ||
Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer | Q36090967 | ||
Concordance of population-based estimates of mammography screening | Q36120839 | ||
The contributions of breast density and common genetic variation to breast cancer risk | Q36137764 | ||
Gene-panel sequencing and the prediction of breast-cancer risk | Q36175072 | ||
Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness | Q37139381 | ||
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model | Q37172219 | ||
Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. | Q39263736 | ||
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial | Q39558136 | ||
Measuring mammography compliance: lessons learned from a survival analysis of screening behavior. | Q40845314 | ||
Screening for cancer: advice for high-value care from the American College of Physicians | Q40928652 | ||
Breast-cancer screening--viewpoint of the IARC Working Group | Q41697220 | ||
The WISDOM Study: breaking the deadlock in the breast cancer screening debate | Q41701590 | ||
Combining risk difference and risk ratio in noninferiority trials of safety | Q46051212 | ||
Breast Cancer Screening With Imaging: Recommendations From the Society of Breast Imaging and the ACR on the Use of Mammography, Breast MRI, Breast Ultrasound, and Other Technologies for the Detection of Clinically Occult Breast Cancer | Q56020322 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P921 | main subject | breast cancer screening | Q17011492 |
P304 | page(s) | pky067 | |
P577 | publication date | 2018-10-01 | |
P1433 | published in | JNCI Cancer Spectrum | Q68836165 |
P1476 | title | The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches | |
P478 | volume | 2 |
Q98184153 | European polygenic risk score for prediction of breast cancer shows similar performance in Asian women |
Q96604435 | Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations |
Q94565385 | RE: The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches |
Q94565393 | Response to Carter et al |
Search more.